Peripheral artery disease treatment: Concept Medical gains FDA approval - Medical Device Network

Peripheral artery disease treatment: Concept Medical gains FDA approval  Medical Device Network

Recognising that this is a market with great potential and no current competition, companies are racing to enter and monopolise the US BTK DCB market.



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more